249 - 260 |
PRODUCTION AND IN-VITRO EVALUATION OF GELATIN MICROSPHERES CONTAINING AN ANTITUMOR TETRA-AMIDINE NASTRUZZI C, PASTESINI C, CORTESI R, ESPOSITO E, GAMBARI R, MENEGATTI E |
261 - 269 |
PHAGOCYTOSIS AND DEGRADATION OF HUMAN SERUM-ALBUMIN MICROSPHERES AND NANOPARTICLES IN HUMAN MACROPHAGES SCHAFER V, VONBRIESEN H, RUBSAMENWAIGMANN H, STEFFAN AM, ROYER C, KREUTER J |
271 - 278 |
PREPARATION AND EVALUATION OF SLOW-RELEASE PAN-COATED INDOMETHACIN GRANULES ESHRA AG, ELKHODAIRY KA, MORTADA SAM, NADA AH |
279 - 286 |
TOPICAL LIPOSOME SYSTEM BEARING LOCAL-ANESTHETIC LIGNOCAINE -PREPARATION AND EVALUATION SHARMA BB, JAIN SK, VYAS SP |
287 - 296 |
SELECTIVE UPTAKE OF LIPOSOMES CONTAINING LACTOSE MONO-FATTY-ACID DERIVATIVES BY HEPATIC PARENCHYMAL-CELLS YAMAUCHI H, KIKUCHI H, SAWADA M, TOMIKAWA M, HIROTA S |
297 - 308 |
EFFECT OF THE SOLVENT NONSOLVENT PAIRS ON THE SURFACE-MORPHOLOGY AND RELEASE BEHAVIOR OF ETHYLCELLULOSE MICROCAPSULES PREPARED BY NON-SOLVENT-ADDITION PHASE-SEPARATION METHOD WU JC, SU SG, SHYU SS, CHEN H |
309 - 318 |
LIPOSOMES AS CARRIERS OF DIFFERENT NEW LIPOPHILIC ANTITUMOR DRUGS - A PRELIMINARY-REPORT SAMPEDRO F, PARTIKA J, SANTALO P, MOLINSPUJOL AM, BONAL J, PEREZSOLER R |
319 - 325 |
LIPOSOMES AS A CARRIER FOR ORAL-ADMINISTRATION OF INSULIN -EFFECT OF FORMULATION FACTORS CHOUDHARI KB, LABHASETWAR V, DORLE AK |
327 - 334 |
SUSTAINED-RELEASE DOSAGE FORM OF PHENYLPROPANOLAMINE HYDROCHLORIDE .1. MICROENCAPSULATION AND IN-VITRO RELEASE KINETICS SEVGI F, OZYAZICI M, GUNERI T |
335 - 344 |
SUSTAINED-RELEASE DOSAGE FORM OF PHENYLPROPANOLAMINE HYDROCHLORIDE .2. FORMULATION AND IN-VITRO RELEASE KINETICS FROM TABLETED MICROCAPSULES SEVGI F, OZYAZICI M, GUNERI T |